Prostate-specific membrane antigen (PSMA), a type II transmembrane glycoprotein, is markedly overexpressed in PCa tissues and is closely associated with tumor aggressiveness, pathological progression, metastatic potential, and castration resistance. Here, FOLH1 is linked to neoplasm.